Are Pfizer and Moderna Shares Declining Due to Covid Vaccine Controversy?
Click to start listening
Synopsis
The stock market sees a notable decline as US health officials plan to connect Covid vaccinations to the deaths of children. This controversial move has raised concerns among scientists and investors alike. What does this mean for the future of Covid vaccinations and public health policy?
Key Takeaways
- Shares of Pfizer and Moderna have sharply declined due to potential vaccine safety concerns.
- The CDC will discuss claims linking Covid vaccines to children's deaths.
- Experts advocate for the safety of Covid vaccines based on extensive research.
- ACIP will meet to evaluate claims and possibly revise vaccination strategies.
- Monitoring of vaccine safety is ongoing globally.
Mumbai, Sep 13 (NationPress) Shares of major US pharmaceutical companies experienced a decline of over 3 percent following reports that suggest the US health authorities aim to link Covid vaccines to the deaths of 25 children.
Pfizer's stock dropped by more than 3 percent, Moderna's shares fell over 7 percent, and Novavax saw a decline of more than 4 percent overnight.
This selloff occurred after revelations that these claims are to be presented next week to the US Centers for Disease Control and Prevention (CDC) vaccine advisory panel, which is responsible for setting US immunization policies.
The American health officials intend to reference pediatric deaths reported in the Vaccine Adverse Event Reporting System (VAERS), a federal repository of unverified reports concerning vaccine side effects, according to a report by The Washington Post.
The CDC has warned that VAERS alone cannot establish a causal relationship between vaccines and deaths.
Experts have expressed concern over the government's approach, arguing that studies have shown that Covid vaccines are safe for children, while the dangers posed by the virus are being minimized.
Data from the CDC as of June indicated that at least 25 children passed away following Covid-related hospitalizations since July 2023, and none of the vaccine-eligible children were current with their vaccinations.
The Advisory Committee on Immunisation Practices (ACIP) will meet next week to evaluate new claims and potentially revise vaccine recommendations.
Various options are being discussed, including one that may limit routine vaccinations for younger adults without preexisting conditions.
In response, Moderna asserted that its vaccine safety is 'rigorously monitored' by regulatory bodies in over 90 countries, with no new safety concerns identified for children or pregnant women.
A recent study published in JAMA Pediatrics, which involved over 10 million children aged 5 to 11 vaccinated with mRNA shots from Pfizer and Moderna, suggested that these vaccines significantly reduced the risk of infection and hospitalization in vaccinated children compared to their unvaccinated counterparts.
Point of View
It is imperative to approach this issue with a balanced perspective. While the linkage of vaccines to tragic outcomes raises serious concerns, the importance of scientific evidence and regulatory oversight cannot be overlooked. Public health policies must be anchored in data-driven research to ensure trust and safety in vaccination efforts.
NationPress
07/01/2026
Frequently Asked Questions
What caused the decline in Pfizer and Moderna shares?
The decline is attributed to reports suggesting that US health officials plan to link Covid vaccines to the deaths of 25 children, raising concerns about vaccine safety.
What is the CDC's stance on the Vaccine Adverse Event Reporting System?
The CDC has cautioned that the Vaccine Adverse Event Reporting System (VAERS) alone cannot prove a causal link between vaccines and deaths.
What do studies say about the safety of Covid vaccines for children?
Studies indicate that Covid vaccines are safe for children, and the risks of Covid itself are being significantly downplayed.
What actions will the Advisory Committee on Immunisation Practices take?
The Advisory Committee on Immunisation Practices (ACIP) will convene to assess new claims regarding vaccines and potentially revise vaccination recommendations.
How are Moderna and Pfizer responding to safety concerns?
Moderna emphasizes that their vaccine safety is rigorously monitored and that no new risks have been identified for children or pregnant women.
